Sylvester Stallone TRT: What It Would Actually Cost a Non-Celebrity

What Stallone Has Said About TRT

Sylvester Stallone has not hidden his use of testosterone. He has discussed it in interviews, on social media, and in documentary footage for decades. The disclosures are direct enough that clinicians can draw a reasonable picture of what his protocol has looked like.

His Own Words

In a 2008 interview with Time magazine following a customs arrest in Australia (where authorities found HGH and testosterone vials in his luggage), Stallone stated plainly that he used both substances and called them part of his recovery routine. He described testosterone as "safe" when used under medical supervision. That case resulted in a fine, not a conviction, because Australian law at the time treated prescribed hormones differently from narcotics.

In more recent years, Stallone has referenced hormone optimization in podcast appearances and on Instagram, framing TRT as a normal part of aging for men who want to maintain physical performance. He has not publicly disclosed exact doses or prescribers, which is consistent with how most public figures discuss medical care.

What Clinical Inference Can Add

Where Stallone has not given specific numbers, clinical inference is the only honest tool. A 78-year-old male (his age as of 2025) with visible muscle mass, reported energy levels, and a decades-long training history would, under standard-of-care protocols, likely be prescribed testosterone cypionate or enanthate in the 100 to 200 mg per week range by injection. Some concierge or age-management physicians prescribe pellet implants or daily topical gels instead. Any inference about his specific current dose is exactly that: inference.

The FDA-Approved Clinical Picture of Male Hypogonadism

Testosterone replacement therapy is not a lifestyle supplement. The FDA approves it specifically for hypogonadism, a condition defined by the Endocrine Society's 2018 clinical practice guideline as a total serum testosterone below 300 ng/dL on two separate morning measurements, combined with signs or symptoms such as decreased libido, fatigue, loss of muscle mass, or erectile dysfunction. [1]

Prevalence and Natural Decline

Testosterone declines at approximately 1 to 2 percent per year after age 30 in healthy men, a figure documented in the Massachusetts Male Aging Study. [2] By age 70, somewhere between 20 and 30 percent of men meet biochemical criteria for hypogonadism. The condition is underdiagnosed. Most primary care visits do not include routine testosterone screening unless symptoms are reported.

Diagnosis Requirements

Two morning blood draws showing total testosterone below 300 ng/dL remain the standard diagnostic threshold. The Endocrine Society guideline states: "We suggest measurement of morning total testosterone concentration by an accurate and reliable assay as the initial diagnostic test." [1] Free testosterone measurement becomes relevant when sex hormone-binding globulin is suspected to be elevated, which is common in older and obese men.

Testosterone Cypionate: The Workhorse of TRT

Testosterone cypionate is the most commonly prescribed TRT formulation in the United States. It is a long-acting esterified testosterone injected subcutaneously or intramuscularly, typically once or twice per week to minimize serum peaks and troughs. The FDA-approved labeling for testosterone cypionate covers dosing from 50 to 400 mg every two to four weeks for hypogonadism, though most contemporary protocols split this into weekly dosing for more stable levels. [3]

Why Weekly Beats Biweekly

Biweekly injections of 200 mg create a supraphysiologic peak around day 3 to 4 and a subtherapeutic trough by day 14. Weekly injections of 100 mg produce a much flatter curve. A 2021 study in Andrology compared injection frequencies and found that weekly administration produced significantly less peak-to-trough variability and better patient-reported symptom control. [4]

Alternatives to Injection

Topical gels (AndroGel 1.62%, Testim, Axiron), transdermal patches, buccal tablets, and subcutaneous pellets are all FDA-approved alternatives. Gels carry a transfer risk to partners and children; the FDA added a black-box warning about secondary exposure in 2009. Pellets, inserted every 3 to 6 months under local anesthesia, appeal to patients who want to avoid weekly injections. Cost varies considerably across these options.

Cardiovascular Safety: The TRAVERSE Trial Data

The biggest long-standing clinical debate about TRT was cardiovascular risk. That question got a large, well-controlled answer in 2023.

TRAVERSE Results

The TRAVERSE trial enrolled 5,198 hypogonadal men aged 45 to 80 with pre-existing cardiovascular disease or high cardiovascular risk. Participants received testosterone gel 1.62% or placebo for a median of 22 months. The primary endpoint was a composite of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke. Results published in the New England Journal of Medicine showed a 7.0% event rate in the testosterone group versus 7.3% in placebo, meeting the pre-specified non-inferiority margin (hazard ratio 0.96, 95% CI 0.78 to 1.17). [5]

The trial authors wrote: "Testosterone replacement therapy was noninferior to placebo with respect to the incidence of major adverse cardiac events in men with hypogonadism." [5]

What TRAVERSE Did Not Clear

TRAVERSE found higher rates of atrial fibrillation (3.5% vs. 2.4%), pulmonary embolism (0.9% vs. 0.5%), and acute kidney injury in the testosterone group. These findings were not primary endpoints, but they are clinically meaningful. Patients with prior atrial fibrillation or thromboembolic history require careful risk-benefit discussion before starting TRT.

Hematocrit Monitoring

Testosterone stimulates erythropoiesis, raising red blood cell mass and hematocrit. A hematocrit above 54% is a standard threshold for dose reduction or temporary treatment hold. The Endocrine Society guideline recommends checking hematocrit at 3 to 6 months after initiation and annually thereafter. [1]

Prostate Safety: Current Evidence

PSA monitoring remains standard practice. The long-held "testosterone feeds prostate cancer" hypothesis has been substantially revised. A 2023 systematic review in JAMA Oncology of 11 randomized controlled trials found no statistically significant increase in prostate cancer incidence with TRT compared to placebo in men without pre-existing prostate cancer (relative risk 1.08, 95% CI 0.67 to 1.74). [6] Men with active prostate cancer or a rising PSA after treatment remain contraindicated for TRT under current guidelines.

Baseline PSA before TRT initiation and a repeat at 3 to 6 months is the minimum monitoring standard. A rise of more than 1.4 ng/mL above baseline within the first 12 months warrants urology referral.

What Stallone's Protocol Would Cost a Non-Celebrity

This is the core question. The numbers below are based on 2025 US pricing from pharmacy benefit managers, direct-pay telehealth platforms, and compounding pharmacies. They assume a standard protocol: testosterone cypionate 100 to 200 mg per week by injection.

Medication Costs

Branded testosterone cypionate (Watson, Pfizer) runs $60 to $120 for a 10 mL vial (200 mg/mL) at retail pharmacy. A 10 mL vial lasts 5 to 10 weeks depending on weekly dose. Generic testosterone cypionate at large chain pharmacies, particularly with GoodRx, drops to $25 to $45 per vial. Annual medication cost at 100 mg per week: approximately $130 to $250.

Topical testosterone gels cost considerably more. AndroGel 1.62% (30-day supply) lists at over $500 per month brand-name; generic testosterone gel runs $80 to $140 per month out of pocket.

Pellet insertion costs $400 to $800 per procedure, with procedures needed every 3 to 6 months, putting annual pellet costs at $800 to $3,200 not including the physician fee.

Physician and Monitoring Costs

A TRT initiation visit at a primary care office or urology practice costs $150 to $350 without insurance. Telehealth TRT platforms (Defy Medical, Maximus, HeathRX-style concierge services) charge $99 to $199 per month as an all-inclusive subscription covering labs, consultations, and medication shipment.

Lab monitoring twice per year, covering testosterone panel, complete blood count, PSA, estradiol, and comprehensive metabolic panel, adds $200 to $600 per year at retail lab pricing. With insurance or a telehealth bundle, this cost is often absorbed.

Total Annual Cost Estimates by Care Model

Primary care with generic injections: $500 to $1,200 per year.

Urology practice with name-brand injections and full labs: $1,500 to $3,000 per year.

Telehealth TRT subscription with included labs: $1,200 to $2,400 per year.

Concierge age-management physician with pellets and concierge labs: $4,000 to $8,000 per year.

A celebrity with access to a personal physician and compounding pharmacy has essentially no ceiling, but the clinical floor is low. A non-celebrity on a basic protocol can access medically sound TRT for well under $100 per month.

Ancillary Medications Often Prescribed Alongside TRT

Several medications commonly accompany TRT protocols, especially in men who are concerned about estrogen conversion or fertility preservation.

Anastrozole

Testosterone aromatizes to estradiol. Some men on TRT develop elevated estradiol (above 42 pg/mL), producing symptoms like water retention, mood changes, or decreased libido. Anastrozole 0.25 to 0.5 mg twice weekly is sometimes prescribed. Generic anastrozole costs $15 to $30 per month. The Endocrine Society does not recommend routine aromatase inhibitor use; it is reserved for symptomatic elevations confirmed by lab. [1]

hCG and Fertility Preservation

Testosterone suppresses the hypothalamic-pituitary-gonadal axis, reducing endogenous LH and FSH and causing testicular atrophy with markedly reduced sperm production. Human chorionic gonadotropin (hCG) at 500 to 1,500 IU two to three times per week maintains testicular size and intratesticular testosterone for men concerned about fertility. A 2020 review in Translational Andrology and Urology confirmed that co-administration of hCG with TRT preserves spermatogenesis in the majority of men, though it does not guarantee fertility. [7] hCG costs $80 to $200 per month at compounding pharmacies.

Enclomiphene and Clomiphene

For men with secondary hypogonadism (low T with normal or low LH) who want to preserve fertility, enclomiphene citrate (25 mg daily) or clomiphene citrate (25 to 50 mg daily) stimulates endogenous testosterone production by blocking estrogen receptors at the hypothalamus. These options do not suppress sperm production. Enclomiphene is not FDA-approved for hypogonadism but is prescribed off-label. Generic clomiphene costs $20 to $50 per month.

Human Growth Hormone: Stallone's Other Reported Compound

The 2008 Australian customs case involved both testosterone and HGH vials. Stallone has been more circumspect about HGH in public statements, but the combination is common in age-management medicine circles.

Clinical Status of HGH in Aging Men

The FDA approves recombinant human growth hormone (somatropin) for adult growth hormone deficiency, not for age-related decline. A 2007 meta-analysis in the Annals of Internal Medicine reviewing 31 trials found that GH administration in healthy older adults increased lean mass by 2 kg and decreased fat mass by 2.1 kg but did not improve physical strength or function, and produced edema, arthralgias, and carpal tunnel syndrome in a meaningful proportion of subjects. [8] Using HGH outside of documented GH deficiency is not supported by current guidelines.

Cost of HGH

Somatropin, even at low doses (0.1 to 0.3 mg daily), costs $500 to $2,000 per month. This is where celebrity and non-celebrity diverge most sharply. A basic TRT protocol is accessible on any moderate budget. HGH is not.

How to Start TRT Through a Legitimate Provider

The path to a legitimate TRT prescription in the United States follows a straightforward sequence. A patient reports symptoms, gets two morning testosterone blood draws at least one week apart, confirms a reading below 300 ng/dL on both, rules out secondary causes (prolactinoma, hemochromatosis, opioid use), and receives a prescription from a licensed physician.

Telehealth platforms have made this process significantly faster. Many complete the diagnostic phase within one week. The American Urological Association's 2018 guideline on testosterone deficiency specifies that "testosterone therapy should only be offered to patients with confirmed testosterone deficiency and consistent signs and symptoms." [9]

Red flags for patients to watch for: providers who prescribe TRT without confirming a low baseline testosterone level, or who do not monitor hematocrit and PSA. Those practices fall outside the standard of care regardless of what celebrities report using.